LRRK2 and Parkinson disease: Several gain-of-function (GOF) mutations in the Leucine-Rich RepeatKinase 2 (LRRK2, PARK8) gene have been identified in sporadic and familial PD patients (Lesage et al., 2007), of which the G2019S mutant is best described.